General Information of the Compound
Compound ID
CP0174612
Compound Name
2-[6-(5-chloro-2-methoxyphenyl)-4-oxo-2-sulfanylidenepyrimidin-1-yl]acetamide
    Show/Hide
Synonyms
PF-06282999
    Show/Hide
Structure
Formula
C13H12ClN3O3S
Molecular Weight
325.777
Canonical SMILES
COc1ccc(Cl)cc1-c1cc(=O)[nH]c(=S)n1CC(N)=O
    Show/Hide
InChI
InChI=1S/C13H12ClN3O3S/c1-20-10-3-2-7(14)4-8(10)9-5-12(19)16-13(21)17(9)6-11(15)18/h2-5H,6H2,1H3,(H2,15,18)(H,16,19,21)
    Show/Hide
InChIKey
ICYNYWFGIDGBRD-UHFFFAOYSA-N
CAS
1435467-37-0
Physicochemical Property
logP
1.72019
Rotatable Bonds
4
Heavy Atom Count
21
Polar Areas
90.11
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71571306
SID: 163598052
ChEMBL ID
CHEMBL3633460
DrugBank ID
DB11683
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02317, Myeloperoxidase
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000018 HL-60 Homo sapiens (Human)  1
1
IC50 = 35500 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 187 nM
2 IC50 = 1900 nM
Clinical Information about the Compound
Drug 1 ( PF-06282999 )
Drug Name PF-06282999
Company Pfizer
Indication
Acute coronary syndrome
Phase 1